Inovio Pharmaceuticals (INO) Income from Non-Controlling Interests (2010 - 2020)
Inovio Pharmaceuticals (INO) posted Income from Non-Controlling Interests of -$469407.0 for Q2 2020, up 21.02% sequentially from -$594350.0 in Q1 2020, and down 144.67% YoY from $1.1 million in Q3 2019.
Inovio Pharmaceuticals (INO) Income from Non-Controlling Interests (2010 - 2020) Analysis & Trends
Inovio Pharmaceuticals has reported Income from Non-Controlling Interests for 8 years, with the latest figure at -$469407.0 in Q2 2020.
- Quarterly Income from Non-Controlling Interests fell 144.67% year-over-year to -$469407.0 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was -$469407.0 (up 72.67% YoY) and the FY2020 annual result came in at -$1.1 million, up 10.8% from the prior year.
- Income from Non-Controlling Interests climbed to -$469407.0 in Q2 2020 per INO's latest filing, from -$594350.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$69605.0 in Q1 2019 and troughed at -$594350.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 63.60 Mn |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -469,407.00 |
| Mar 31, 2020 | -594,350.00 |
| Dec 31, 2019 | -485,344.00 |
| Sep 30, 2019 | -445,759.00 |
| Jun 30, 2019 | -191,850.00 |
| Mar 31, 2019 | -69,605.00 |
| Jun 30, 2015 | 85,861.00 |
| Mar 31, 2015 | -1,092.00 |
| Dec 31, 2014 | -1,083.00 |
| Sep 30, 2014 | -1,486.00 |
| Jun 30, 2014 | -6,443.00 |
| Mar 31, 2014 | -9,408.00 |
| Dec 31, 2013 | -13,473.00 |
| Sep 30, 2013 | -13,443.00 |
| Jun 30, 2013 | -14,008.00 |
| Mar 31, 2013 | -14,160.00 |
| Dec 31, 2012 | -12,553.00 |
| Sep 30, 2012 | -10,413.00 |
| Jun 30, 2012 | -11,289.00 |
| Mar 31, 2012 | -9,770.00 |